NYSE : KVUE
-$0.07 (-0.36%)
NYSE
Kirk L. Perry
Household & Personal Products
Consumer Defensive
KVUE
22000
US
USD
0.82
0.98
0.70
0.18
0.00
$15.12B
2.42
3.48
20.26
0.95
$0.76
$1.47B
10.61%
14.47%
15.18%
6.04%
22.64
0.41
0.41
$19.00
$20.00
$18.00
3/5
14 Analysts
1.26%
2.25
6/9
-$101M
$26.85B
$16.25B
$2.61B
$44.66B
2.92
14.09
0.98
15.18%
9.76%
4.38%
4.92%
$10.26
20 days
| Name | Title |
|---|---|
| Caroline Tillett | Chief Scientific Officer |
| Anil Agarwal | Head of Total Rewards |
| Jonathan Halvorson | Chief Digital & Marketing Officer |
| Matthew Orlando | General Counsel |
| Michael Wondrasch | Chief Technology & Data Officer |
| Heather R. Howlett | Interim CFO & Chief Accounting Officer |
| Kirk L. Perry | Chief Executive Officer & Director |
| Sofya Tsinis | Head of Investor Relations |
| Meredith Stevens | Chief Operations Officer |
| Carlton Lawson | Group President of Europe, Middle East & Africa |
No votes yet today — be the first to share your view!
About Kenvue Inc. (NYSE:KVUE) Stock
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands lik ... e Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Kenvue's Q2 Earnings Coming Up: Here's What Lies Ahead of the Stock
2026-07-31 14:26:09
KVUE is expected to post Q2 revenue and earnings growth as brand strength, innovation and productivity efforts offset seasonal and cost pressures.
Kenvue Benefits From Consumer Health Trends and Margin Expansion
2026-07-29 11:41:21
Kenvue's beauty momentum, margin expansion and stronger cash flow support its outlook as uneven demand and deal uncertainty temper visibility.
Is Kenvue Stock Attractive After Margin Gains and Deal Uncertainty
2026-07-29 11:41:18
KVUE's margin gains and stronger cash flow boost its appeal, but slow organic growth, debt and deal uncertainty keep the outlook balanced.
Kenvue's Brand Strength and Growth Drivers Shape Its Future Outlook
2026-07-29 11:41:06
KVUE's trusted brands, margin gains and pending Kimberly-Clark deal shape its outlook amid mixed growth signals.
Kenvue Increases Quarterly Cash Dividend
2026-07-29 06:45:00
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock, which represents a 1.2 percent increase compared to the prior quarterly dividend. The quarterly dividend is payable on August 26, 2026, to shareholders of record as of the close of business on August 12, 2026. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a cent.
5 Dividend Kings Continued to Pay and Raise Dividends Through Every Market Crash Since Black Monday
2026-07-27 08:20:10
Black Monday was on Monday, October 19, 1987, almost 40 years ago, and market veterans and long-time investors usually mention one important item: nobody really saw it coming or expected it.
Kenvue Inc. $KVUE Shares Acquired by Gabelli Funds LLC
2026-07-27 04:27:37
Gabelli Funds LLC increased its stake in Kenvue Inc. (NYSE: KVUE) by 71.2% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 724,635 shares of the company's stock after acquiring an additional 301,350 shares during the period. Gabelli Funds LLC's holdings in Kenvue were
Analysts Set Kenvue Inc. (NYSE:KVUE) Price Target at $19.58
2026-07-26 01:45:11
Kenvue Inc. (NYSE: KVUE - Get Free Report) has been given an average recommendation of "Hold" by the sixteen research firms that are covering the firm, MarketBeat.com reports. Thirteen equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price target
Frequently Asked Questions
What is the current Kenvue Inc. (KVUE) stock price?
Kenvue Inc.(NYSE:KVUE) stock price is $19.24 in the last trading session. During the trading session, KVUE stock reached the peak price of $22.285 while $14.02 was the lowest point it dropped to. The percentage change in KVUE stock occurred in the recent session was --0.36% while the dollar amount for the price change in KVUE stock was -$0.07.
KVUE's industry and sector of operation?
The NYSE listed KVUE is part of Household & Personal Products industry that operates in the broader Consumer Defensive sector.
Who are the executives of KVUE?
Caroline Tillett
| Chief Scientific Officer
Anil Agarwal
| Head of Total Rewards
Jonathan Halvorson
| Chief Digital & Marketing Officer
Matthew Orlando
| General Counsel
Michael Wondrasch
| Chief Technology & Data Officer
How many employees does KVUE have?
Number of KVUE employees currently stands at 22000. KVUE operates from 1 Kenvue Way, Summit, NJ 07901, US.
Link for KVUE official website?
Official Website of KVUE is: https://www.kenvue.com
How do I contact KVUE?
KVUE could be contacted at phone #908 874 1200 and can also be accessed through its website. KVUE operates from 1 Kenvue Way, Summit, NJ 07901, US.
How many shares of KVUE are traded daily?
The average number of KVUE shares traded daily for last 3 months was 20.64M.
What is the market cap of KVUE currently?
The market value of KVUE currently stands at $36.94B with its latest stock price at $19.24